The United States will distribute 25 million Covid vaccines as part of the initial tranche of 80 million doses that President Biden has pledged to share internationally, Covid-1
The United States will distribute 25 percent of that first tranche bilaterally, Smith said.
“This gives us more flexibility, and as we’ve seen, there are a lot of pop-ups and signals in this pandemic, and we want to be able to move vaccines urgently if necessary,” Smith said. She added that the “current expectation” is for the vaccines to be manufactured by AstraZeneca.
The remaining 75% of the first tranche of US vaccines will go to COVAX, the international group focused on the global distribution of vaccines, Smith said, adding that the Biden administration “has identified the countries we want these vaccines to go to.”
Approximately 6 million doses will be distributed in Latin America, including the Caribbean, 7 million will go to South and Southeast Asia and 5 million to Africa, Smith said.
“This is the first round, this is just the beginning,” Smith said. She could not say when the 55 million doses, which make up a total of 80 million vaccines, would be delivered.
From now on, the Biden administration will pursue a three-part strategy to maximize vaccine supply through dose-sharing, encouraging U.S. manufacturers to increase vaccine production “by the last quarter, if not earlier, this year and next,” Smith said. . The administration will also work to improve vaccine production worldwide by increasing production capacity, “so that there are more places in the world to produce and distribute vaccines,” Smith said.
“Our goal is to end the pandemic and increase it as quickly as possible,” Smith said. “It’s in our best interest to do that. Our own health security is at risk … none of us are safe while we’re all safe.”